MedPath

Versameb AG

Versameb AG logo
🇨🇭Switzerland
Ownership
Holding
Established
2017-07-31
Employees
11
Market Cap
-
Website
http://www.versameb.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

A Phase 2a Study To Evaluate VMB-100 In Females With Stress Urinary Incontinence

Phase 2
Not yet recruiting
Conditions
Stress Urinary Incontinence
Interventions
First Posted Date
2024-02-07
Last Posted Date
2025-04-01
Lead Sponsor
Versameb AG
Target Recruit Count
30
Registration Number
NCT06247241

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.